Abstract:Background/aims: The major histocompatibility class II (MHC II) transactivator, known as CIITA, is induced by Interferon gamma (IFN-γ) and plays a well-established role in regulating the expression of class II MHC molecules in antigen-presenting cells. Methods: Primary human hepatocytes (PHH) were isolated via therapeutic hepatectomy from two donors. The hepatocellular carcinoma (HCC) cell lines HepG2 and Huh7 were used for the mechanistic study, and HBV infection was performed in HepG2-NTCP cells. HBV DNA replication intermediates and secreted antigen levels were measured using Southern blotting and ELISA, respectively. Results: We identified a non-canonical function of CIITA in the inhibition of hepatitis B virus (HBV) replication in both HCC cells and patient-derived PHH. Notably, in vivo experiments demonstrated that HBV DNA and secreted antigen levels were significantly decreased in mice injected with the CIITA construct. Mechanistically, CIITA inhibited HBV transcription and replication by suppressing the activity of HBV-specific enhancers/promoters. Indeed, CIITA exerts antiviral activity in hepatocytes through ERK1/2-mediated down-regulation of the expression of hepatocyte nuclear factor 1α (HNF1α) and HNF4α, which are essential factors for virus replication. In addition, silencing of CIITA significantly abolished the IFN-γ-mediated anti-HBV activity, suggesting that CIITA mediates the anti-HBV activity of IFN-γ to some extent. HBV X protein (HBx) counteracts the antiviral activity of CIITA via direct binding and impairing its function. Conclusion: Our findings reveal a novel antiviral mechanism of CIITA that involves the modulation of the ERK pathway to restrict HBV transcription. Additionally, our results suggest the possibility of a new immune avoidance mechanism involving HBx.

Effects of CIITA Antisense RNA on the Expression of HLA Class II Molecules

Small interfering RNA targeting LASS2 gene enhances invasion capacity of hepatocellular carcinoma cells

Epigenetic Modification and Preliminary Investigation of the Mechanism of the Immune Evasion of HL-60 Cells

CIITA versus IFN-γ induced MHC class II expression in head and neck cancer cells

Downregulating Immunogenicity of Schwann Cells Via Inhibiting A Potential Target of Class Ii Transactivator (ciita) Gene

Efficient Inhibition of Human Cytomegalovirus UL122 Gene Expression in Cell by Small Interfering RNAs

Down-Regulation Of Mhc Class Ii Expression Through Inhibition Of Ciita Transcription By Lytic Transactivator Zta During Epstein-Barr Virus Reactivation

Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells

[Inhibition of HLA-DRB1*0405 Gene Expression by Sirna].

Human dominant-negative class II transactivator transgenic pigs - effect on the human anti-pig T-cell immune response and immune status

Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction

Mutated major histocompatibility complex class II transactivator up-regulates interleukin-33-dependent differentiation of Th2 subset through Nod2 binding for NLR (NOD-like receptor) signaling initiation

Functional Disruption of Human Leukocyte Antigen Ii in Human Embryonic Stem Cell

Irf-4-Mediated Ciita Transcription Is Blocked By Kshv Encoded Lana To Inhibit Mhc Ii Presentation

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

Inhibited Neoplastic Phenotype by the C-Ha-ras Antisense RNA.

TLR Agonists Inhibit IL-27-Induced HLA-DR Expression in THP-1 Cells

Transduction of MHC Gene Induces Transplantation Tolerance ( I )- Transduction of H-2k~b Gene into Mice Hematopoietic Cells

Induction of lymphocyte apoptosis in rat liver allograft by adenoviral gene transfection of human interleukin-10.

[The Inhibitory Effect of Hyporesponsive Peptide on Human Leukocyte Antigen-Drbeta1 Specific T Cell Activation].

The Effect of Altered CII Peptides on HLA-DRB1 Restricted T Cell Responses